Jason Lavinder

Jason Lavinder is a Research Assistant Professor in the Department of Chemical Engineering at the University of Texas at Austin. His research focuses on high-throughput profiling of antibody repertoires using BCR-Seq and Ig-Seq technologies to study adaptive immune responses against pathogens like SARS-CoV-2, influenza, HIV, and malaria. He holds a Ph.D. in Biochemistry from The Ohio State University (2009). His work emphasizes understanding antibody lineage dynamics and their role in protective immunity.

Key research areas include:

• Antibody structure-function relationships
• Vaccine efficacy evaluation through antibody repertoire analysis
• Mechanisms of immune imprinting in viral infections
• Development of novel antibody discovery platforms

Recent studies highlight his team’s contributions to SARS-CoV-2 immunity, including hybrid immunity mechanisms and antibody recognition of non-RBD spike epitopes. Collaborations with institutions like the Baric Lab and McLellan Lab have advanced vaccine design and pathogen-specific immune profiling.

Lavinder’s lab is affiliated with the Georgiou group, focusing on antibody engineering and proteomic approaches. His work bridges chemical engineering principles with immunology, enabling quantitative insights into humoral immune responses.